Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient

In an era when cardiac transplant patients are surviving more immediate issues of rejection and infection, the prevalence of more chronic issues such as cardiac allograft vasculopathy (CAV) is rising. This case describes a man 20 years after cardiac transplant with his first presentation of CAV. Acu...

Full description

Bibliographic Details
Main Authors:	Felicity J. Lee, MBBS, Imran Shiekh, MBBS, Thach Nguyen, Michael Nguyen, MBBS
Format:	Article
Language:	English
Published:	Compuscript 2018-07-01
Series:	Cardiovascular Innovations and Applications
Subjects:	Coronary artery disease
Online Access:	http://www.ingentaconnect.com/content/cscript/cvia/2018/00000003/00000002/art00008

id	doaj-c30c2463cb8d4243b2c4a811f56154c6
record_format	Article
spelling	doaj-c30c2463cb8d4243b2c4a811f56154c62020-11-24T23:41:11ZengCompuscriptCardiovascular Innovations and Applications2009-86182009-87822018-07-013222723110.15212/CVIA.2017.0019Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant PatientFelicity J. Lee, MBBS0Imran Shiekh, MBBS1Thach Nguyen2Michael Nguyen, MBBS3Fiona Stanley Hospital, Department of Cardiology, Murdoch, WA, AustraliaFiona Stanley Hospital, Department of Cardiology, Murdoch, WA, AustraliaMethodist Hospital, Department of Cardiovascular Research, Merrillville IN, USAFiona Stanley Hospital, Department of Cardiology, Murdoch, WA, AustraliaIn an era when cardiac transplant patients are surviving more immediate issues of rejection and infection, the prevalence of more chronic issues such as cardiac allograft vasculopathy (CAV) is rising. This case describes a man 20 years after cardiac transplant with his first presentation of CAV. Acute myocardial infarction was diagnosed on the basis of symptoms and biochemical markers and on coronary angiography, and he was found to have a critical stenosis of the midportion of the left anterior descending artery. It was elected to treat this percutaneously with a fully bioresorbable vascular scaffold (BVS) because of the diffuse nature of the disease process. This was successfully performed with optical coherence tomography guidance. The use of BVS in CAV has not been well studied. This is one of few case reports describing the use of BVS in CAV.http://www.ingentaconnect.com/content/cscript/cvia/2018/00000003/00000002/art00008Coronary artery disease
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Felicity J. Lee, MBBS Imran Shiekh, MBBS Thach Nguyen Michael Nguyen, MBBS
spellingShingle	Felicity J. Lee, MBBS Imran Shiekh, MBBS Thach Nguyen Michael Nguyen, MBBS Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient Cardiovascular Innovations and Applications Coronary artery disease
author_facet	Felicity J. Lee, MBBS Imran Shiekh, MBBS Thach Nguyen Michael Nguyen, MBBS
author_sort	Felicity J. Lee, MBBS
title	Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient
title_short	Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient
title_full	Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient
title_fullStr	Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient
title_full_unstemmed	Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient
title_sort	bioresorbable vascular scaffold in the midportion of the left anterior descending artery for cardiac allograft vasculopathy in a cardiac transplant patient
publisher	Compuscript
series	Cardiovascular Innovations and Applications
issn	2009-8618 2009-8782
publishDate	2018-07-01
description	In an era when cardiac transplant patients are surviving more immediate issues of rejection and infection, the prevalence of more chronic issues such as cardiac allograft vasculopathy (CAV) is rising. This case describes a man 20 years after cardiac transplant with his first presentation of CAV. Acute myocardial infarction was diagnosed on the basis of symptoms and biochemical markers and on coronary angiography, and he was found to have a critical stenosis of the midportion of the left anterior descending artery. It was elected to treat this percutaneously with a fully bioresorbable vascular scaffold (BVS) because of the diffuse nature of the disease process. This was successfully performed with optical coherence tomography guidance. The use of BVS in CAV has not been well studied. This is one of few case reports describing the use of BVS in CAV.
topic	Coronary artery disease
url	http://www.ingentaconnect.com/content/cscript/cvia/2018/00000003/00000002/art00008
work_keys_str_mv	AT felicityjleembbs bioresorbablevascularscaffoldinthemidportionoftheleftanteriordescendingarteryforcardiacallograftvasculopathyinacardiactransplantpatient AT imranshiekhmbbs bioresorbablevascularscaffoldinthemidportionoftheleftanteriordescendingarteryforcardiacallograftvasculopathyinacardiactransplantpatient AT thachnguyen bioresorbablevascularscaffoldinthemidportionoftheleftanteriordescendingarteryforcardiacallograftvasculopathyinacardiactransplantpatient AT michaelnguyenmbbs bioresorbablevascularscaffoldinthemidportionoftheleftanteriordescendingarteryforcardiacallograftvasculopathyinacardiactransplantpatient
_version_	1725507898055852032

Bioresorbable Vascular Scaffold in the Midportion of the Left Anterior Descending Artery for Cardiac Allograft Vasculopathy in a Cardiac Transplant Patient

Similar Items